Cargando…
Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study
Objective. To evaluate fracture incidence, effects on health-related quality of life(QoL), back pain (BP) occurrence and treatment compliance in Greek post-menopausal osteoporotic women treated with teriparatide (TPTD) for up to 18 months, in a naturalistic setting. Methods. 301 patients provided ba...
Autores principales: | Aloumanis, K., Karras, D., Drossinos, V., Korelis, E., Polydorakis, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176524/ https://www.ncbi.nlm.nih.gov/pubmed/21941680 http://dx.doi.org/10.4061/2011/510398 |
Ejemplares similares
-
Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS)
por: Aloumanis, Kyriakos, et al.
Publicado: (2015) -
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012) -
Effects of teriparatide in postmenopausal women with osteoporosis
pre-treated with bisphosphonates: 36-month results from the European Forsteo
Observational Study
por: Jakob, F, et al.
Publicado: (2012) -
Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study
por: Ljunggren, Östen, et al.
Publicado: (2013) -
Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)
por: Langdahl, Bente L., et al.
Publicado: (2009)